Walter Rotkis
Ophthalmology · Seattle, WANPI 1952470767
Payments from drug & device makers
Across 137 payments — averaging $30.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe US, Inc.$2K
- Glaukos Corporation$1K
- Oyster Point Pharma, Inc.$288
- Novartis$245
- Sun Pharmaceutical Industries Inc.$244
- Johnson & Johnson Surgical Vision, Inc.$203
- plus $436 from 8 others
What the payments were for
- Food & beverage$4,182100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe US, Inc. | 68 | $1,682 |
| Glaukos Corporation | 9 | $1,084 |
| Oyster Point Pharma, Inc. | 7 | $288 |
| Novartis | 12 | $245 |
| Sun Pharmaceutical Industries Inc. | 15 | $244 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $203 |
| AbbVie | 8 | $145 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $112 |
| Kala Pharmaceuticals, Inc. | 3 | $63 |
| Thea Pharma Inc. | 2 | $43 |
| Akorn, Inc. | 1 | $24 |
| Aerie Pharmaceuticals, Inc. | 1 | $20 |
| Omeros Corporation | 1 | $18 |
| Katena Products, Inc. (dba Corza Medical) | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject W$695
- KXL System$434
- Photrexa$274
- IACCESS$261
- iDose$188
- TYRVAYA$163
- iStent$161
How this compares
$4,182 in reported general payments places this provider in the 75th percentile of 428 ophthalmology providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 11 | $163 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Seattle
- Laura PerimanSeattle$1.9M
- Sheldon CowenSeattle$560K
- Raghu MudumbaiSeattle$284K
- Jennifer ChaoSeattle$212K
- Kathryn PeppleSeattle$143K
- Debarshi MustafiSeattle$85K
- Michelle CabreraSeattle$75K
- Paul GriggsSeattle$62K
- Aaron KuzinSeattle$59K
- Lisa Olmos de KooSeattle$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.